Dr. Lewis has been Dartmouth PI on a first in man study of the combination of cyclophosphamide pretreatment with a humanized immunoconjugate of an anti-EpCAM antibody linked to two molecules of IL - 2. (cancer.dartmouth.edu)
Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte - macrophage colony - stimulating factor - secreting breast tumor vaccine: a chemotherapy dose - ranging study of safety and immune activation. (hopkinsmedicine.org)
The scientists began to use post-transplant cyclophosphamide in clinical trials of fully matched bone marrow transplants in 2004. (sciencedaily.com)